Impact of Kinesiotaping Application on… | Clinical Trial

Key information

Conditions

Pelvic Girdle Pain Female Urogenital Diseases and Pregnancy Complications Kinesiotaping Musculoskeletal Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Pelvic Pain Pregnancy Complications Signs and Symptoms Urogenital Diseases

Age range

18 year–36 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

out-patient clinic, faculty of physical therapy, Cairo university

Cairo, Egypt

About this study

Severity of pelvic girdle pain can be different, as a result of the progress of the disorders and subjective feeling of pain. According to Kanakaris an average severity of pain in pelvic girdle pain is 50-60 mm scale visual analogue scale. Results may vary according to different factors such as; pregnancy stage, age of the pregnant women, different body mass index. Beyond the discomfort and pain, pelvic girdle pain can also limit the performance of the activities of daily living such as; bending, lifting, sitting, sleeping, housework, long walking, and standing and thus adversely affect the quality of life of pregnant women. Unfortunately, the options for pain therapy in pregnant women are significantly limited due to the possible danger to both mother and fetus. Most of the standard drugs used affect the fetus and are not recommended, especially for long-term treatment.

There is very little clinical experience and only limited documentation for effectiveness of Kinesio taping on pelvic girdle pain during pregnancy. Because the existing treatments for pregnancy-related pelvic girdle pain are not adequately known and are not found to be reliable by patients and clinicians. Kinesio taping may be a potential treatment if it is an effective and tolerable method. Therefore, the aim of the present study was to determine the influence of Kinesio taping pelvic girdle pain in pregnant women

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age: 18-36 years old.
Gestational age: 10-34 week of pregnancy.
Low back pain experienced anywhere from T12 to the gluteal fold without leg pain, and at least moderate pain intensity (scoring ≥4 on visual analogue scale)
At least one positive test out of three applied, which are Long Dorsal Ligament Test (modified for pregnant women), Posterior Pelvic Pain Provocation (4P), and Trendelenburg test (modified for pregnant women).
Negative Straight Leg Raise test

Exclusion criteria

History of abortion
pregnancy of twins
previous of pelvic injury.
Skin previous injury in the lumbosacral area.
Positive Straight Leg Raise test
Negative diagnostic tests for pelvic girdle pain
Chronic pelvic diseases.
History of allergies to material of kinesiotape.

Treatment and study plan

Kinesio Tape

Other

Kinesio taping is a drug-free elastic therapeutic technique developed by Dr. Kenso Kase in the 1970s, utilized for treating various musculoskeletal issues, including pain and dysfunction. It is known for having no side effects, contributing to its popularity among practitioners. In a study, participants underwent five days of Kinesio taping applied by the same therapist, focusing on the lumbar region of pregnant women. The tape used was an elastic, waterproof material that allows for motion, applied in specific vertical and horizontal configurations to alleviate lumbar and pelvic girdle pain.

Core Stability Exercises

Other

All participants will do core exercise. The control group (Group A) received no additional treatment. The core exercises were in form exercises that promote bracing or excessively increasing trunk muscle activation Popular core stability exercise programs commonly focus on bracing or activating the trunk muscles that are believed to support the spine. This includes exercises such as: crunches, planks, bird-dogs

Primary outcomes

assessment of pain intensity

Time frame: At baseline and after 2 weeks

Visual Analogue Scale (VAS) is a widely used method for assessing pain intensity, functioning as a subjective measure of treatment efficacy. It involves marking a point on a 10-cm line that indicates pain levels from "no pain" to "worst pain." Studies validate VAS as a reliable interval scale for measuring both acute and chronic pain, making it a useful tool in clinical practice. Pain levels are measured before and after 5 days of treatment, followed by another recording after re-application of the tape after an additional 5 days.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2025
First posted: Dec 18, 2025
Registry last updated: Dec 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed